We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BOSTON SCIENTIFIC LOWERS FORECAST, REMAINS UPBEAT
BOSTON SCIENTIFIC LOWERS FORECAST, REMAINS UPBEAT
September 3, 2004
Despite Boston Scientific’s contention that the multiple recalls of its Taxus drug-eluting stent have had little effect on the firm’s financial situation, the company warned Wall Street analysts last week that it might fall short of its third- and fourth-quarter earnings projections.